title: The need for new therapeutic approaches in visceral leishmaniasis during HIV infection.
authors.forename: A
authors.initials: A
authors.lastname: Lafeuillade
authors.forename: R
authors.initials: R
authors.lastname: Quilichini
authors.forename: C
authors.initials: C
authors.lastname: Dhiver
authors.forename: C
authors.initials: C
authors.lastname: Mary
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy*
chemical_list: D008536:Meglumine; D007371:Interferon-gamma